IP Verse

Assay For Jc Virus Antibodies - EP3339865

The patent EP3339865 was granted to Biogen MA on Dec 14, 2022. The application was originally filed on Jan 11, 2011 under application number EP17203178A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3339865

BIOGEN MA
Application Number
EP17203178A
Filing Date
Jan 11, 2011
Status
Granted And Under Opposition
Jul 22, 2022
Grant Date
Dec 14, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

POLPHARMA BIOLOGICSMay 23, 2023WICHMANNADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS3817837
DESCRIPTIONUS3850752
DESCRIPTIONUS3939350
DESCRIPTIONUS3996345
DESCRIPTIONUS4275149
DESCRIPTIONUS4277437
DESCRIPTIONUS4366241
EXAMINATIONUS2007207141
EXAMINATIONWO2010090757
OPPOSITIONWO2011085369
OPPOSITIONWO2012166971
OTHERUS2007207141
OTHERWO2010090757
OTHERWO2011085369
SEARCHUS6238859

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- EGLI et al., J. Infect. Dis., (20090000), vol. 199, pages 837 - 846-
DESCRIPTION- PICCINNI et al., "Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents", Eur. J. Clin. Pharmacol., (20100000), vol. 66, pages 199 - 206, XP019778034-
DESCRIPTION- PADGETT; WALKER, "Prevalence of antibodies in human sera agains JC virus, an isolate from a case of progressive multifocal leukoencephalopathy", J. Infect. Dis., (19730000), vol. 127, doi:doi:10.1093/infdis/127.4.467, pages 467 - 70, XP009171995
DESCRIPTION- MAJOR, "Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies", Annu. Rev. Med., (20100000), vol. 61, doi:doi:10.1146/annurev.med.080708.082655, pages 35 - 47, XP055162302
EXAMINATION- CARTER J J ET AL, "Lack of serologic evidence for prevalent simian virus 40 infection in humans", JNCI CANCER SPECTRUM, OXFORD UNIVERSITY PRESS, OXFORD, GB, (20031015), vol. 95, no. 20, doi:10.1093/JNCI/DJG074, ISSN 1475-4029, pages 1522 - 1530, XP002564467
EXAMINATION- R. P. Viscidi ET AL, "Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays", Clinical and Vaccine Immunology, (20030301), vol. 10, no. 2, doi:10.1128/CDLI.10.2.278-285.2003, ISSN 1556-6811, pages 278 - 285, XP055162298
EXAMINATION- EUGENE O. MAJOR, "Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies*", ANNUAL REVIEW OF MEDICINE, (20100201), vol. 61, no. 1, doi:10.1146/annurev.med.080708.082655, ISSN 0066-4219, pages 35 - 47, XP055162302
OPPOSITION- Giuseppe Barbanti-Brodano, "BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors (Chapter 23)", Polyomaviruses and Human Diseases, New York, Springer, (20060101), vol. 577, pages 319 - 341, ISBN 978-0-387-32957-4, XP093156241-
OPPOSITION- Matthew Herper, "https:/ /www.forbes.com/ 2009/10/27 /ms-crohn-elan- business-healthcare-tysabri.html?sh=7ae482d13606", pages 1 - 4, URL: https:/ /www.forbes.com/ 2009/10/27 /ms-crohn-elan- business-healthcare-tysabri.html?sh=7ae482d13606, XP093156260-
OPPOSITION- GORELIK L et al., "Anti-JC virus antibodies: implications for PML risk stratification", Ann Neurol, (20100900), vol. 68, no. 3, doi:10.1002/ana.22128, pages 295 - 303, XP055136721
OPPOSITION- RYSCHKEWITSCH CF et al., "JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab", Ann Neurol, (20100900), vol. 68, no. 3, doi:10.1002/ana.22137, pages 384 - 91, XP055189278
OPPOSITION- TYLER KL, "Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies?", Ann Neurol, (20100900), vol. 68, no. 3, doi:10.1002/ana.22185, pages 271 - 4, XP071639310
OPPOSITION- Viscidi Raphael P., Clayman Barbara, "Serological Cross Reactivity between Polyomavirus Capsids", Polyomaviruses and Human Diseases, New York, Springer, (20060101), vol. 577, pages 73 - 84, doi:10.1007/0-387-32957-9_5, ISSN 0065-2598, ISBN 978-0-387-32957-4, XP093130481
OPPOSITION- CARTER et al., "Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans", Journal of the National Cancer Institute, (20030000), vol. 95, no. 2, doi:10.1093/jnci/djg074, pages 1522 - 1530, XP002564467
OPPOSITION- Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim M R; Noman M; Dillner J; Van Ranst M; Rutgeerts P, "JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?", Gut microbiota, British medical association , London, UK, UK , (20081001), vol. 57, no. 10, doi:10.1136/gut.2007.145698, ISSN 0017-5749, pages 1393 - 1397, XP009172017
OTHER- Anonymous, "Polyomavirus capsid protein (VPl)", Wikipedia, the free encyclopedia, ( ), pages 1 - 5, XP055576331-
OTHER- CARTER et al., "Lack of serologic evidence for prevalent simian virus 40 infection in humans", Journal of the National Cancer Institute, (20030300), vol. 95, no. 2, pages 1522 - 1530, XP002564467
OTHER- VISCIDI et al., "Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays", Clinical and Diagnostic Laboratory Immunology, (20030310), vol. 10, no. 2, pages 278 - 285, XP055162298
SEARCH- GOLDMANN C ET AL, "Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.", JOURNAL OF VIROLOGY MAY 1999, (199905), vol. 73, no. 5, ISSN 0022-538X, pages 4465 - 4469, XP002711817 [A] 1-15 * abstract, page 4465, left-hand column. *-
SEARCH- KNOWLES W A ET AL, "The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy.", CLINICAL AND DIAGNOSTIC VIROLOGY AUG 1995, (199508), vol. 4, no. 2, ISSN 0928-0197, pages 183 - 194, XP008130197 [A] 1-15 * abstract *
SEARCH- VAN ASSCHE GERT ET AL, "Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease", NEW ENGLAND JOURNAL OF MEDICINE, THE -, MASSACHUSETTS MEDICAL SOCIETY, US, (20050728), vol. 353, no. 4, doi:10.1056/NEJMOA051586, ISSN 1533-4406, pages 362 - 368, XP009123817 [A] 1-15 * the whole document *
SEARCH- WEBER T ET AL, "Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.", THE JOURNAL OF INFECTIOUS DISEASES JUL 1997, (199707), vol. 176, no. 1, ISSN 0022-1899, pages 250 - 254, XP002711820 [A] 1-15 * abstract, page 251, left-hand column.; figures 1, 2 *
SEARCH- R. P. VISCIDI ET AL, "Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays", CLINICAL AND VACCINE IMMUNOLOGY, (20030301), vol. 10, no. 2, doi:10.1128/CDLI.10.2.278-285.2003, ISSN 1556-6811, pages 278 - 285, XP055162298 [A] 1-15 * abstract *
SEARCH- ROLLISON DANA E ET AL, "Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION : A PUBLICATION OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, COSPONSORED BY THE AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY MAR 2006, (200603), vol. 15, no. 3, ISSN 1055-9965, pages 543 - 550, XP002711818 [A] 1-15 * abstract, page 544, right-hand column, section "laboratory methods. *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents